Effect of leukopenia on pulmonary hypertension after heparin-protamine in pigs.
Heparin neutralization by protamine after cardiac surgery and cardiopulmonary bypass may be associated with complement activation, transient leukopenia, thromboxane A2 release, and severe pulmonary hypertension. The role of leukocytes in the heparin-protamine reaction was studied in leukopenic pigs (n = 9) and a control group (n = 8). Leukopenia was induced by pretreatment with cyclophosphamide (30 mg.kg-1.day-1) for 6-7 days. During general anesthesia and after catheterization, baseline recordings of hemodynamics were performed and blood samples were withdrawn. Heparin (250 IU/kg) was injected and measurements were repeated after 10 min. Protamine sulfate (100 mg) was then infused over 2 min and measurements were performed after 2, 5, and 15 min. Prostanoid concentrations were measured by radioimmunoassays. In additional in vitro experiments, the release of thromboxane B2 from washed platelets and leukocytes after heparin-protamine stimulation was measured. Pretreatment with cyclophosphamide reduced leukocyte counts by 95.5% and the number of neutrophils by greater than 99.9%. Protamine infusion increased mean pulmonary arterial pressure by 74 and 46% and pulmonary vascular resistance by 185 and 384% in control and leukopenic animals, respectively. Thromboxane B2 concentrations increased in both groups. Stimulation by heparin, protamine, or heparin and protamine in sequence did not induce any thromboxane A2 release from washed blood cells. It is concluded that leukocytes do not contribute to pulmonary hypertension after heparin-protamine.
Habazettl
H
H
Department of Surgery Innenstadt, Klinikum Grosshadern, University of Munich, Federal Republic of Germany.
Conzen
P F
PF
Vollmar
B
B
Yekebas
E
E
Peter
K
K
D000818:Animals; D001784:Blood Gas Analysis; D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism; D003520:Cyclophosphamide; D006439:Hemodynamics; D006493:Heparin; D006976:Hypertension, Pulmonary / Q000139:chemically induced / Q000503:physiopathology*; D066298:In Vitro Techniques; D007958:Leukocyte Count; D007962:Leukocytes / Q000187:drug effects / Q000378:metabolism; D007970:Leukopenia / Q000139:chemically induced / Q000503:physiopathology*; D011453:Prostaglandins / Q000378:metabolism; D011479:Protamines; D011863:Radioimmunoassay; D013552:Swine; D013928:Thromboxane A2 / Q000097:blood
D011453:Prostaglandins; D011479:Protamines; D013928:Thromboxane A2; D003520:Cyclophosphamide; D006493:Heparin